IP Library Granted Patent US 8,198,427
Granted Patent B1
US 8,198,427 · App. 11/980,210 · Granted Jun 12, 2012

SiRNA targeting catenin, beta-1 (CTNNB1)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,198,427
App. No.
11/980,210
Granted
Jun 12, 2012
Kind
B1
Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CTNNB1.

Claims (17)

1. An siRNA molecule, wherein said siRNA molecule consists of: (a) a duplex region; and (b) either no overhangs regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides, wherein the duplex region consists of a sense region and an antisense region, and said sense region and said antisense region are each 19-30 nucleotides in length and said antisense region comprises a sequence that is the complement of SEQ ID NO: 528.

2. The siRNA molecule of claim 1 , wherein said antisense region and said sense region are each 19-25 nucleotides in length.

3. The siRNA molecule of claim 2 , wherein said antisense region and said sense region are each 19 nucleotides in length.

4. The siRNA molecule of claim 1 , wherein said siRNA molecule has at least one overhang region.

5. The siRNA molecule of claim 1 , wherein said siRNA molecule has no overhang regions.

6. The siRNA molecule of claim 2 , wherein said siRNA molecule has at least one overhang region.

7. The siRNA molecule of claim 2 , wherein said siRNA molecule has no overhang regions.

8. The siRNA molecule of claim 3 , wherein said siRNA molecule has at least one overhang region.

9. The siRNA molecule of claim 3 , wherein said siRNA molecule has no overhang regions.

10. A chemically synthesized double-stranded siRNA molecule that directs cleavage of mRNA via RNA interference, wherein:

(a) each strand of said siRNA molecule is between 19 and 30 nucleotides in length; and

(b) one strand of said siRNA molecule comprises a sequence that is the complement of SEQ ID NO: 528.

11. The chemically synthesized double-stranded siRNA molecule of claim 10 , wherein each strand of said siRNA molecule is 19 nucleotides in length.

12. An siRNA molecule consisting of:

(a) a duplex region; and

(b) either no overhang regions or at least one overhang region, wherein each overhang region comprises six or fewer nucleotides,

wherein the duplex region is nineteen base pairs in length and consists of a sense region that has a sequence that is the same as SEQ ID NO: 528 and an antisense region that has a sequence that is the complement of SEQ ID NO: 528.

Assignments (2)
CHANGE OF NAME Recorded Apr 24, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032747/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: THERMO FISHER SCIENTIFIC INC.
Reel/Frame 032723/0262 →